Correlation Between NetSol Technologies and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NetSol Technologies and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NetSol Technologies and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NetSol Technologies and Mereo BioPharma Group, you can compare the effects of market volatilities on NetSol Technologies and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NetSol Technologies with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NetSol Technologies and Mereo BioPharma.

Diversification Opportunities for NetSol Technologies and Mereo BioPharma

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between NetSol and Mereo is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding NetSol Technologies and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and NetSol Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NetSol Technologies are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of NetSol Technologies i.e., NetSol Technologies and Mereo BioPharma go up and down completely randomly.

Pair Corralation between NetSol Technologies and Mereo BioPharma

Given the investment horizon of 90 days NetSol Technologies is expected to under-perform the Mereo BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, NetSol Technologies is 3.07 times less risky than Mereo BioPharma. The stock trades about -0.19 of its potential returns per unit of risk. The Mereo BioPharma Group is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  82.00  in Mereo BioPharma Group on September 8, 2022 and sell it today you would earn a total of  2.00  from holding Mereo BioPharma Group or generate 2.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NetSol Technologies  vs.  Mereo BioPharma Group

 Performance (%) 
       Timeline  
NetSol Technologies 
NetSol Performance
0 of 100
Over the last 90 days NetSol Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2023. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

NetSol Price Channel

Mereo BioPharma Group 
Mereo Performance
0 of 100
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2023. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Mereo Price Channel

NetSol Technologies and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NetSol Technologies and Mereo BioPharma

The main advantage of trading using opposite NetSol Technologies and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NetSol Technologies position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
NetSol Technologies vs. Bondbloxx ETF Trust
NetSol Technologies vs. Merck Company
NetSol Technologies vs. Dupont De Nemours
NetSol Technologies vs. VANGUARD SMALL-CAP GROWTH
The idea behind NetSol Technologies and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Mereo BioPharma vs. Merck Company
Mereo BioPharma vs. Johnson Johnson
Mereo BioPharma vs. Bondbloxx ETF Trust
Mereo BioPharma vs. Fidelity MSCI Energy
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go